What’s Moving These Hot Stocks: SodaStream, Pluristem Therapeutics, Chiquita Brands

SodaStream International Ltd. (NASDAQ:SODA) shares jump following first quarter results that easily beat consensus, plus a heightened guidance for 2012, as the company says that its decision to expand worldwide is affirmed by the figures. Earnings per share of 55 cents handily exceeded estimates of 35 cents, and sales of soda machines increased 15 percent year-to-year and sales of CO2 refills 29 percent. Sales of flavors soared by 52 percent and the company projects that its net income will rise 50 percent in fiscal 2012, year-to-year, compared to an earlier forecast of 42 percent.

Don’t Miss: Are We Really Getting Three New Apple Goodies This Year?

Pluristem Therapeutics, Inc. (NASDAQ:PSTI) reported that a seven year-old girl suffering from an aplastic bone marrow, whose condition was rapidly deteriorating, is now seeing a reversal of her condition with a significant increase in her red cells, white cells and platelets, after an intramuscular injection of the company’s PLacental eXpanded, or PLX, cells. Aplastic bone marrow is a condition in which the patient has no blood-forming hematopoietic stem cells in the bone marrow.

Chiquita Brands International Inc. (NYSE:CQB) gets its rating reduced from Buy to Hold by Jefferies, as well as its earnings forecasts cut and price target moved down to $7.50. Observers note that the company is moving ‘to the sidelines’ with no improvement in sight near term, and also with sales in Europe slumping.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

Don’t Miss: Einhorn and Ron Paul on Bernanke’s Wealth Effect Fed Policy.